| Entry |
|
|---|
| Name |
Cisplatin (JP16/USP/INN);
Platinol (TN)
|
|---|
| Product |
|
|---|
| Generic |
|
|---|
| Formula |
PtCl2. 2NH3
|
|---|
| Exact mass |
298.9556
|
|---|
| Mol weight |
300.051
|
|---|
| Structure |
     |
|---|
| Activity |
|
|---|
| Remark |
Same as: Therapeutic category: ATC code: |
|---|
| Metabolism |
Transporter: SLC22A2 [HSA: 6582]
|
|---|
| Interaction |
Genomic biomarker: TPMT [HSA: 7172]
 |
|---|
| Structure map |
| Antineoplastics - alkylating agents |
|
|---|
| Brite |
Therapeutic category of drugs in Japan [BR:br08301]
4 Agents affecting cellular function
42 Antineoplastics
429 Miscellaneous
4291 Other Antitumors
D00275 Cisplatin (JP16/USP/INN)
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L01 ANTINEOPLASTIC AGENTS
L01X OTHER ANTINEOPLASTIC AGENTS
L01XA Platinum compounds
L01XA01 Cisplatin
D00275 Cisplatin (JP16/USP/INN)
Antineoplastics [BR:br08308]
Alkylating agents
Platinum compounds
Cisplatin [ATC:L01XA01]
D00275 Cisplatin (JP16/USP/INN)
 |
|---|
| Other DBs |
CAS: 15663-27-1 PubChem: DrugBank: NIKKAJI: |
|---|
| KCF data |
ATOM 5
1 Z Pt 34.5801 -25.8301
2 X Cl 35.9846 -25.8301
3 X Cl 34.5743 -27.2286
4 N0 N 31.9200 -25.8300
5 N0 N 33.8100 -24.0800
BOND 2
1 1 2 1
2 1 3 1
|
|---|
